购物车
- 全部删除
- 您的购物车当前为空
FMK-MEA is a potent and selective p90 Ribosomal S6 Kinase (RSK) inhibitor.
FMK-MEA is a potent and selective p90 Ribosomal S6 Kinase (RSK) inhibitor.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 16,100 | 10-14周 | |
50 mg | ¥ 21,300 | 10-14周 | |
100 mg | ¥ 27,500 | 10-14周 |
产品描述 | FMK-MEA is a potent and selective p90 Ribosomal S6 Kinase (RSK) inhibitor. |
体外活性 | FMK-MEA treatment inhibits RSK2 kinase activity in diverse, highly invasive human cancer cell lines including 212LN, M4e, A549, and SKBR3 cells.?Treatment with the RSK-specific inhibitor FMK-MEA significantly attenuates RSK2 activity, as assessed by the phosphorylation levels of Ser-386 and the consequent invasive ability of A549 cells.FMK-MEA is a water-soluble derivative of fmk. |
体内活性 | FMK-MEA treatment has no effect on the tumor size, and the proliferation rate of the primary tumor.FMK-MEA treatment (80 mg/kg/day for 16 days by intraperitoneal injection) in highly metastatic M4e cell xenograft nude mice results in a significant attenuation of LN metastasis. |
分子量 | 399.46 |
分子式 | C21H26FN5O2 |
CAS No. | 1414811-15-6 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容